JPMorgan Resumes Nektar Therapeutics (NKTR) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 38.42 +0.66 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.76 | 52 Week High | $19.98 | |||
| Open | $38.98 | 52 Week Low | $10.52 | |||
| Day High | $39.19 | P/E | N/A | |||
| Day Low | $38.40 | EPS | $-1.45 | |||
| Volume | 40,662 | |||||
